C1–C2-linker substituted 1, 5-naphthyridine analogues of oxabicyclooctane-linked NBTIs as broad-spectrum antibacterial agents (part 7). Issue 10 (25th August 2015)
- Record Type:
- Journal Article
- Title:
- C1–C2-linker substituted 1, 5-naphthyridine analogues of oxabicyclooctane-linked NBTIs as broad-spectrum antibacterial agents (part 7). Issue 10 (25th August 2015)
- Main Title:
- C1–C2-linker substituted 1, 5-naphthyridine analogues of oxabicyclooctane-linked NBTIs as broad-spectrum antibacterial agents (part 7)
- Authors:
- Singh, Sheo B.
Kaelin, David E.
Wu, Jin
Miesel, Lynn
Tan, Christopher M.
Meinke, Peter T.
Olsen, David B.
Lagrutta, Armando
Wei, Changqing
Liao, Yonggang
Peng, Xuanjia
Wang, Xiu
Fukuda, Hideyuki
Kishii, Ryuta
Takei, Masaya
Shibata, Takeshi
Takeuchi, Tomoko
Ohata, Kohei
Nishimura, Akinori
Fukuda, Yasumichi - Abstract:
- Abstract : Substitutions around linker positions C-1 and C-2 suggest that the C-2α hydroxy group is the best for activity. Abstract : Novel bacterial topoisomerase inhibitors (NBTIs) are a recent class of broad-spectrum antibacterial agents targeting bacterial DNA gyrase and topoisomerase IV at a site distinct from quinolone binding. They are not cross-resistant to known antibiotics and present an excellent opportunity to combat drug-resistant bacteria. We have recently reported a series of oxabicyclooctane-linked inhibitors describing the structure–activity relationship around left-hand-side and right-hand-side moieties. In this report, SAR of the benzylic (C-1) and homobenzylic (C-2) positions of the linker moiety has been described. Single and double substitutions by polar and charged (OH, NH2, CO2 H) and non-polar (F, Me) groups indicated that a hydroxy substitution at the benzylic or homobenzylic position is preferred for the potency and spectrum. The C-1, 2-dihydroxy group was not effective. Amino substitution at C-2 provides a marginal advantage to the Gram-negative activity. It appears that the α-hydroxy enantiomer was preferred. Despite the beneficial effects of C-1 hydroxy–C-1 alkyl substitution in the tricyclics (particularly for attenuation of hERG), methyl tert -carbinols either at C-1 or C-2 had a detrimental effect on the activity without having much effect on the hERG signal. Mono-hydroxy compounds at C-1 and C-2 showed improved intravenous (ED50 2–4 mg kg −1Abstract : Substitutions around linker positions C-1 and C-2 suggest that the C-2α hydroxy group is the best for activity. Abstract : Novel bacterial topoisomerase inhibitors (NBTIs) are a recent class of broad-spectrum antibacterial agents targeting bacterial DNA gyrase and topoisomerase IV at a site distinct from quinolone binding. They are not cross-resistant to known antibiotics and present an excellent opportunity to combat drug-resistant bacteria. We have recently reported a series of oxabicyclooctane-linked inhibitors describing the structure–activity relationship around left-hand-side and right-hand-side moieties. In this report, SAR of the benzylic (C-1) and homobenzylic (C-2) positions of the linker moiety has been described. Single and double substitutions by polar and charged (OH, NH2, CO2 H) and non-polar (F, Me) groups indicated that a hydroxy substitution at the benzylic or homobenzylic position is preferred for the potency and spectrum. The C-1, 2-dihydroxy group was not effective. Amino substitution at C-2 provides a marginal advantage to the Gram-negative activity. It appears that the α-hydroxy enantiomer was preferred. Despite the beneficial effects of C-1 hydroxy–C-1 alkyl substitution in the tricyclics (particularly for attenuation of hERG), methyl tert -carbinols either at C-1 or C-2 had a detrimental effect on the activity without having much effect on the hERG signal. Mono-hydroxy compounds at C-1 and C-2 showed improved intravenous (ED50 2–4 mg kg −1 ) and oral (ED50 2–5 mg kg −1 ) efficacy in a mouse model of bacteremia of S. aureus infection. … (more)
- Is Part Of:
- MedChemComm. Volume 6:Issue 10(2015:Oct.)
- Journal:
- MedChemComm
- Issue:
- Volume 6:Issue 10(2015:Oct.)
- Issue Display:
- Volume 6, Issue 10 (2015)
- Year:
- 2015
- Volume:
- 6
- Issue:
- 10
- Issue Sort Value:
- 2015-0006-0010-0000
- Page Start:
- 1773
- Page End:
- 1780
- Publication Date:
- 2015-08-25
- Subjects:
- Pharmaceutical chemistry -- Periodicals
615.19 - Journal URLs:
- http://pubs.rsc.org/en/journals/journalissues/md ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/c5md00297d ↗
- Languages:
- English
- ISSNs:
- 2040-2503
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5424.685000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 563.xml